An audit was undertaken of time lost from work and reasons given to employers for absence in a group of patients attending a city centre outpatients department. For the audit a Department of Genito-urinary Medicine was selected and 54 patients were interviewed. The time lost by attendance and the reasons given are discussed as are ways of improving medical care through new treatments and altered appointment times.
Introduction
Audit is a systematic and structured procedure with the purpose of improving medical care. Any outpatient department or medical condition could have been chosen for study. However patients with genital warts were selected because of their need to attend clinics frequently for many weeks, because the condition is rapidly increasing in incidence and because warts are usually a sexually transmitted disease, so I was interested in the reasons that the patients gave to their employers to explain their frequent absences.
Genital warts are an infectious disease caused by human papillomavirus (HPV) which not only cause considerable embarrassment for those affected but also discomfort and inconvenience from treatment and the use of a large amount of hospital and patient time. Until recently genital warts were considered relatively benign but studies have now shown that they are associated with other sexually transmitted diseases 1 and a link has been suggested with some types of HPV and carcinoma of the cervix 2 . Recent years have seen an increase in the number of cases of genital warts 3 with 75 000 cases reported in the late 1980's, a 266 per cent increase on the 1980 figures. Treatment is largely hospital based because of the risk of severe dermatitis and the very important need for screening for other infections. It consists of once or twice weekly applications of podophyllin (20 per cent) or trichloroacetic acid with cryotherapy used for solitary warts or where podophyllin has failed to bring about resolution after applications for three to four weeks. Because of its carcinogenic potential it is not used on pregnant women, for longer than four weeks or for self administration. Most studies compare the efficacy of treatments by results at three months however visits may need to be continued for a further several months to effect a complete cure. Recurrence of warts is common even after seemingly successful treatment.
Patients and Methods
A study was undertaken of 54 consecutive patients attending a city centre Department of Genito-urinary Medicine with a clinical diagnosis of genital warts.
Current employment was a prerequisite for entry into the study. All were interviewed by the same doctor (NW)
Results
All 54 subjects agreed to participate, 33 (61 per cent) were male and 21 (39 per cent) female. Table I shows the ages and treatment details of subjects. Despite the average amount of time lost being 2.2 hours for men and 1.6 hours for women per treatment session some subjects took whole days off work even though the actual treatment itself took only minutes to apply. The average number of treatments shows how many visits had been made, given the average time taken for each visit, a rough estimate of time lost at the point of the study was 24.2 hours (male) and 12.8 hours (female).
Table II records the employers response to absence and reasons given by the subjects. The study group is small and definite conclusions cannot be drawn but it is interesting that a third of women told their employer of their exact diagnosis whereas men tended to give a more general explanation (e.g. going to the hospital).
Only 66 per cent of women lost time from work for treatment compared to 85 per cent of men, women seemed more likely to arrange their appointments around flexible working hours than men.
Discussion
The unwillingness of people to reveal the exact reason for their absence is understandable if they are seeking treatment for genital warts, but the difference between male and female rates of disclosure is interesting. It may be that women are more accustomed to being open about health issues or respond differently to being questioned, the group however is too small to draw any definite conclusions. Further studies would be needed to assess if a true difference exists.
The study group reported a low level of enquiry by employers into repeated absences, only about a quarter asked for additional information. The reasons for this are not known but may include collusion by colleagues in covering absences or the employer simply not noticing.
The audit has attempted to quantify time lost whilst undergoing a course of treatment that is hospital based and therefore expensive in terms of resources. It highlights the cost to the individual and the employer. The cost of the treatment is approximately 30 p for 20 per cent podophyllin made up in a hospital pharmacy (Dr D. White, personal communication) however no costing for medical staff of screening tests is available. A new compound called podophyllotoxin (0.5 per cent) has been used in clinical trials with some success. Although licensed only for use in men with preputial warts it may be self administered at home following the initial screening appointments. In terms of a comparison of the efficacy of the two compounds podophyllotoxin was found to have cured significantly more patients at four weeks than podophyllin 4 ' 5 , however in the latter study relapse rates were the same after 3 to 6 months. The newer compound still however, has the same irritant side effects and at £6 costs considerably more but would save the NHS, the individual and the employer hours of lost time.
The audit was useful because: it attempted to quantify individuals time lost from work whilst undergoing treatment for this particular condition; it indicated a possible difference between male and female absence behaviour; it identified the newer compound which although much more expensive to buy and having the same efficacy would be less expensive in terms of hospital staffing and waste less time for the individuals; during the course of the study several subjects expressed a wish for an evening or lunchtime clinic which would reduce time lost from work further. (The clinic ran along office hours with the final appointment at 16.30 h.)
Occupational physicians and nurses when looking at sickness absence should be alert to the possibility of a diagnosis of genital warts when employees have frequent and repeated absence that they may be hesitant to discuss.
